Bellevue Asset Management »

Infinity Pharmaceuticals shares owned by Bellevue Asset Management

Quarter-by-quarter ownership of Infinity Pharmaceuticals (INFIQ) shares owned by Bellevue Asset Management from 13F filings

Historical chart of Bellevue Asset Management investment in Infinity Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Infinity Pharmaceuticals held by Bellevue Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Infinity Pharmaceuticals by Bellevue Asset Management

Quarter filed Position value Share count Share price at filing
2015-12-31 $1.3M 160k 7.85
2015-09-30 $1.1M 130k 8.45
2015-06-30 $1.8M 164k 10.95
2015-03-31 $2.3M 164k 13.98

More positions owned by Bellevue Asset Management

Celgene Corporation
Biogen Idec (BIIB)
Gilead Sciences (GILD)
Amgen (AMGN)
Regeneron Pharmaceuticals (REGN)
Medtronic
Illumina (ILMN)
Abbott Laboratories (ABT)
Mylan
Becton, Dickinson and (BDX)
Cardinal Health (CAH)
UnitedHealth (UNH)
Stryker Corporation (SYK)
Teva Pharmaceutical Industries (TEVA)
Express Scripts Holding

View all positions for Bellevue Asset Management

Top funds holding Infinity Pharmaceuticals

Highlander Capital Management
Able Wealth Management
Livelsberger Financial Advisory

View all funds holding Infinity Pharmaceuticals